Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

Dr Fuh, welcome to the Medscape InDiscussion: Endometrial Cancer podcast ... more with endometrioid histology, and copy number high, which is more serous-like. Matulonis: We've had a discussion ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient (dMMR), surgically resectable endometrial cancer, according to findings presented at the SGO 2025 Annual ...

Puxitatug samrotecan (P-Sam), an investigational antibody-drug conjugate (ADC) targeting B7-H4-expressing tumors, showed promising efficacy in patients with advanced or metastatic endometrial cancer, ...

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer ... of these patients had endometrioid histology, and 15% had unknown mismatch ...